Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06558825 · ClinicalTrials.gov registry record · NA

Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions

A NA study of Substance Use, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06558825: Recruiting NA study of Substance Use, sponsored by The University of Texas Health Science Center, Houston.

NCT06558825 is a NA study of Substance Use that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06558825, a NA study of Substance Use, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The investigators have previously developed an integrated bio-behavioral intervention to promote PrEP uptake and adherence in cisgender women who are undergoing treatment for trauma-related mental health conditions and who are at a higher risk for HIV. The intervention is delivered within the mental health treatment setting and integrates knowledge, behavioral skills, and motivation to engage in and adhere to PrEP care. The purpose of this study is to assess the preliminary efficacy, feasibility, and acceptability of this intervention. The hypothesis is that, compared to standard treatment, the intervention will be feasible, acceptable, and associated with greater PrEP uptake and adherence.

Primary Outcome

PrEP uptake is defined as obtaining a prescription and taking the first dose.

Conditions Studied

Substance Use

Interventions

  • BEHAVIORAL Integrated Intervention to Promote PrEP Uptake
  • OTHER Standard Treatment Condition

Study Locations (1)

Texas

  • Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-10-01
Est. Completion 2025-06-30
Phase NA
The University of Texas Health Science Center, Houston

732 total trials

What NCT06558825 shows while recruiting

NCT06558825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Integrated Intervention to Promote PrEP Uptake is the first listed.

NCT06558825 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06558825 about?

NCT06558825 is a clinical study titled "Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions". The investigators have previously developed an integrated bio-behavioral intervention to promote PrEP uptake and adherence in cisgender women who are undergoing treatment for trauma-related mental health conditions and who are at a higher risk for HIV. The intervention is delivered within the mental...

What is the current status of trial NCT06558825?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-01. Estimated completion is 2025-06-30.

What conditions does trial NCT06558825 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT06558825?

The interventions under investigation include: Integrated Intervention to Promote PrEP Uptake (BEHAVIORAL), Standard Treatment Condition (OTHER).

Who is sponsoring clinical trial NCT06558825?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06558825 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06558825's enrollment target sits among peer trials

60 71st of 88 higher than 15 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06558825

Source: ClinicalTrials.gov NCT06558825, the US trial registry maintained by the National Library of Medicine. NCT06558825 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.